Literature DB >> 20005220

Autologous bone marrow mesenchymal cell transplantation improves left ventricular function in a rabbit model of dilated cardiomyopathy.

Yanjun Chen1, Wei Liu, Weimin Li, Cheng Gao.   

Abstract

BACKGROUND: Bone marrow mesenchymal stem cells (BMSCs) could differentiate into cardiomyocytes. In this study, we wished to determine whether we could improve ventricular function in a dilated cardiomyopathy (DCM) model in the rabbit by injecting stem cells directly into the ventricular wall. METHODS AND
RESULTS: Japanese rabbits were treated with doxorubicin to induce dilated cardiomyopathy. BMSCs were isolated from isogenic adult rabbits and expanded ex vivo. DCM-model animals received an injection directly into the ventricular wall with either BMSCs or saline (sham-operated control; a third control group underwent no operation). Heart function in all three groups was evaluated by echocardiography and cardiac catheterization. Hearts were later excised for histological and immunostaining analysis. Left ventricular function was significantly better in BMSC-transplanted animals than in controls. Cellular staining of BrdU and N-cadherin, indicating the presence of bone-marrow-derived cells, was found in BMSC-transplanted animals but not in control and sham-operated animals.
CONCLUSIONS: BMSC transplantation can improve left ventricular function in DCM. Direct injection into the ventricular wall is an effective approach for stem cell delivery. Crown Copyright 2009. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20005220     DOI: 10.1016/j.yexmp.2009.12.002

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  6 in total

Review 1.  The emerging therapeutic role of mesenchymal stem cells in anthracycline-induced cardiotoxicity.

Authors:  Huanrong Lan; Qi Xue; Yuyao Liu; Ketao Jin; Xingliang Fang; Hong Shao
Journal:  Cell Tissue Res       Date:  2021-01-12       Impact factor: 5.249

2.  Doxorubicin Cardiotoxicity and Cardiac Function Improvement After Stem Cell Therapy Diagnosed by Strain Echocardiography.

Authors:  Maira S Oliveira; Marcos B Melo; Juliana L Carvalho; Isabela M Melo; Mario Sl Lavor; Dawidson A Gomes; Alfredo M de Goes; Marilia M Melo
Journal:  J Cancer Sci Ther       Date:  2013

3.  Effect of neuroglobin genetically modified bone marrow mesenchymal stem cells transplantation on spinal cord injury in rabbits.

Authors:  Wen-Ping Lin; Xuan-Wei Chen; Li-Qun Zhang; Chao-Yang Wu; Zi-Da Huang; Jian-Hua Lin
Journal:  PLoS One       Date:  2013-05-02       Impact factor: 3.240

4.  Randomised, double-blind, placebo-controlled clinical trial for evaluating the efficacy of intracoronary injection of autologous bone marrow mononuclear cells in the improvement of the ventricular function in patients with idiopathic dilated myocardiopathy: a study protocol.

Authors:  Miguel Romero; José Suárez-de-Lezo; Concha Herrera; Manuel Pan; José López-Aguilera; José Suárez-de-Lezo; Flor Baeza-Garzón; Francisco Javier Hidalgo-Lesmes; Olga Fernández-López; Juliana Martínez-Atienza; Eva Cebrián; Vanesa Martín-Palanco; Rosario Jiménez-Moreno; Rosario Gutiérrez-Fernández; Sonia Nogueras; Maria Dolores Carmona; Soledad Ojeda; Natividad Cuende; Rosario Mata
Journal:  BMC Cardiovasc Disord       Date:  2019-08-22       Impact factor: 2.298

Review 5.  Efficacy and Mode of Action of Mesenchymal Stem Cells in Non-Ischemic Dilated Cardiomyopathy: A Systematic Review.

Authors:  Cecilie Hoeeg; Sabina Frljak; Abbas Ali Qayyum; Bojan Vrtovec; Jens Kastrup; Annette Ekblond; Bjarke Follin
Journal:  Biomedicines       Date:  2020-12-05

6.  Therapeutic angiogenesis promotes efficacy of human umbilical cord matrix stem cell transplantation in cardiac repair.

Authors:  Kaveh Moradi; Mehdi Abbasi; Farid Aboulhasani; Niloufar Abbasi; Kehinde Adebayo Babatunde; Fereydoon Sargolzaeiaval; Ahmad-Reza Dehpour
Journal:  Iran J Basic Med Sci       Date:  2015-06       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.